Cargando…

New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia

INTRODUCTION: Chagas disease (CD) affects ~7 million people worldwide. Benznidazole (BZN) and nifurtimox (NFX) are the only approved drugs for CD chemotherapy. Although both drugs are highly effective in acute and paediatric infections, their efficacy in adults with chronic CD (CCD) is lower and var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alonso-Vega, Cristina, Urbina, Julio A, Sanz, Sergi, Pinazo, María-Jesús, Pinto, Jimy José, Gonzalez, Virginia R, Rojas, Gimena, Ortiz, Lourdes, Garcia, Wilson, Lozano, Daniel, Soy, Dolors, Maldonado, Rosa A, Nagarkatti, Rana, Debrabant, Alain, Schijman, Alejandro, Thomas, M Carmen, López, Manuel Carlos, Michael, Katja, Ribeiro, Isabela, Gascon, Joaquim, Torrico, Faustino, Almeida, Igor C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720984/ https://www.ncbi.nlm.nih.gov/pubmed/34972765 http://dx.doi.org/10.1136/bmjopen-2021-052897

Ejemplares similares

Characterization of digestive disorders of patients with chronic Chagas disease in Cochabamba, Bolivia
por: Pinto, Jimy-Jose, et al.
Publicado: (2019)

Mental health in the Plurinational State of Bolivia
por: Garcia, Monica
Publicado: (2011)

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease
por: Torrico, Faustino, et al.
Publicado: (2022)

Multi-criteria decision analysis approach for strategy scale-up with application to Chagas disease management in Bolivia
por: Pinazo, Maria-Jesus, et al.
Publicado: (2021)

Teseo /
por: Gide, André, 1869-1951
Publicado: (2001)

A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform
por: Pinazo, Maria-Jesus, et al.
Publicado: (2017)

Indigenous language and inequitable maternal health care, Guatemala, Mexico, Peru and the Plurinational State of Bolivia
por: Paulino, Nancy Armenta, et al.
Publicado: (2019)

Results and evaluation of the expansion of a model of comprehensive care for Chagas disease within the National Health System: The Bolivian Chagas network
por: Pinazo, Maria-Jesus, et al.
Publicado: (2022)

Description and phylogeny of a new species of Liolaemus (Iguania: Liolaemidae) endemic to the south of the Plurinational State of Bolivia
por: Abdala, Cristian Simón, et al.
Publicado: (2019)

Achievements and Challenges upon the Implementation of a Program for National Control of Congenital Chagas in Bolivia: Results 2004–2009
por: Alonso-Vega, Cristina, et al.
Publicado: (2013)

Teseo alucinado y otros minotauros
por: García Ramírez, Sergio
Publicado: (1984)

Use of rapid diagnostic tests (RDTs) for conclusive diagnosis of chronic Chagas disease – field implementation in the Bolivian Chaco region
por: Lozano, Daniel, et al.
Publicado: (2019)

Trypanosoma cruzi-infected Panstrongylus geniculatus and Rhodnius robustus adults invade households in the Tropics of Cochabamba region of Bolivia
por: Rojas-Cortez, Mirko, et al.
Publicado: (2016)

Genetic polymorphism of Trypanosoma cruzi bloodstream populations in adult chronic indeterminate Chagas disease patients from the E1224 clinical trial
por: Ramírez, Juan Carlos, et al.
Publicado: (2021)

Usefulness of Serial Blood Sampling and PCR Replicates for Treatment Monitoring of Patients with Chronic Chagas Disease
por: Parrado, Rudy, et al.
Publicado: (2019)

Strengthening the Bolivian pharmacovigilance system: New surveillance strategies to improve care for Chagas disease and tuberculosis
por: Cortes-Serra, Nuria, et al.
Publicado: (2020)

Social determinants in the access to health care for Chagas disease: A qualitative research on family life in the “Valle Alto” of Cochabamba, Bolivia
por: Jimeno, I., et al.
Publicado: (2021)

Improved Completion Rates and Characterization of Drug Reactions with an Intensive Chagas Disease Treatment Program in Rural Bolivia
por: Tornheim, Jeffrey A., et al.
Publicado: (2013)

Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis
por: Egüez, Karina E., et al.
Publicado: (2017)

The burden of congenital Chagas disease and implementation of molecular diagnostic tools in Latin America
por: Picado, Albert, et al.
Publicado: (2018)

First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease
por: Ramírez, Juan C., et al.
Publicado: (2017)

Aptamer Based, Non-PCR, Non-Serological Detection of Chagas Disease Biomarkers in Trypanosoma cruzi Infected Mice
por: Nagarkatti, Rana, et al.
Publicado: (2014)

Aptamer-Based Detection of Disease Biomarkers in Mouse Models for Chagas Drug Discovery
por: de Araujo, Fernanda Fortes, et al.
Publicado: (2015)

Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia
por: Ballart, Cristina, et al.
Publicado: (2021)

Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus
por: Alonso-Padilla, Julio, et al.
Publicado: (2020)

A tribute to Cecilio Romaña: Romaña’s sign in Chagas disease
por: Beucler, Nathan, et al.
Publicado: (2020)

Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis
por: Ciapponi, Agustín, et al.
Publicado: (2020)

Los silencios de Procusto y los esfuerzos de Teseo : discapacidades y accesibilidades universitarias e indígenas /
Publicado: (2022)

"I Cannot Be Worried": Living with Chagas Disease in Tropical Bolivia
por: Forsyth, Colin J.
Publicado: (2017)

The CUIDA Chagas Project: towards the elimination of congenital transmission of Chagas disease in Bolivia, Brazil, Colombia, and Paraguay
por: de Sousa, Andréa Silvestre, et al.
Publicado: (2022)

In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2019)

Corrigendum: In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2020)

Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial
por: Carmona-Bayonas, Alberto, et al.
Publicado: (2022)

Usefulness of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in the Characterization of Leishmania Strains Causing Tegumentary Leishmaniasis in Bolivia versus hsp70 Gene Sequencing
por: Torrico, Mary Cruz, et al.
Publicado: (2023)

Immunosuppression and Chagas Disease: A Management Challenge
por: Pinazo, María-Jesús, et al.
Publicado: (2013)

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives
por: Pinazo, Maria-Jesus, et al.
Publicado: (2015)

Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease
por: Martínez-Peinado, Nieves, et al.
Publicado: (2021)

Ecological host fitting of Trypanosoma cruzi TcI in Bolivia: mosaic population structure, hybridization and a role for humans in Andean parasite dispersal
por: Messenger, Louisa A., et al.
Publicado: (2015)

A novel Trypanosoma cruzi secreted antigen as a potential biomarker of Chagas disease
por: Nagarkatti, Rana, et al.
Publicado: (2020)

Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response
por: Pinazo, Maria-Jesus, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4hqk621rldr4n4b299sqkmp344